LMAT

LeMaitre Vascular, Inc.
$97.92
-0.89 (-0.90%)
Mkt Cap 2.24B
Volume 88,133
52W Range 79.01-118.01
Sector Healthcare
Beta 0.52
EPS (TTM) 2.76
P/E Ratio 35.59
Revenue (TTM) 256.28M
Rev Growth (5Y) +14.0%
EPS Growth (5Y) +19.4%
AlphaVal · Fair Value
What we estimate one share is worth
$111.21
Fair Value weak signal
11.7% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B+
Platform & Compounding FCF
75.6 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 249.60M 219.86M 193.48M 161.65M 154.42M 129.37M 117.23M 105.57M 100.87M 89.15M 78.35M 71.10M
Net Income 57.73M 44.04M 30.11M 20.64M 26.91M 21.22M 17.93M 22.94M 17.18M 10.59M 7.76M 3.92M
EPS 2.55 1.96 1.36 0.94 1.27 1.05 0.91 1.18 0.91 0.57 0.44 0.24
Free Cash Flow 74.47M 37.16M 29.49M 22.15M 30.22M 31.82M 10.42M 16.45M 16.45M 14.05M 9.15M 4.32M
FCF / Share 3.29 1.66 1.33 1.01 1.43 1.57 0.53 0.85 0.87 0.76 0.51 0.26
Operating CF 81.25M 44.12M 36.75M 25.38M 35.10M 34.80M 14.18M 19.51M 22.87M 16.90M 11.44M 5.51M
Total Assets 615.69M 551.82M 346.78M 310.48M 292.80M 252.81M 188.34M 153.09M 126.32M 101.92M 90.70M 81.49M
Total Debt 185.59M 185.69M 19.09M 16.60M 15.94M 54.78M 15.71M 0 0 0 0 0
Cash & Equiv 28.24M 25.61M 24.27M 19.13M 13.86M 26.76M 11.79M 26.32M 19.10M 24.29M 27.45M 18.69M
Book Value 393.52M 337.29M 297.90M 268.20M 254.15M 172.57M 148.14M 130.24M 109.77M 87.50M 77.88M 68.21M
Return on Equity 0.15 0.13 0.10 0.08 0.11 0.12 0.12 0.18 0.16 0.12 0.10 0.06
LMAT News
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
Jul 14, 2026 01:43 PM · globenewswire.com
We Have A Valuation Problem - May Dividend Income Report
Jun 18, 2026 11:26 AM · seekingalpha.com
Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now
May 26, 2026 06:56 AM · zacks.com
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
May 25, 2026 09:46 AM · zacks.com
LeMaitre to Participate at Upcoming Investor Conferences in June
May 20, 2026 12:25 PM · globenewswire.com
Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround
May 13, 2026 06:35 AM · zacks.com
LeMaitre to Present at the Bank of America Healthcare Conference
May 07, 2026 01:15 PM · globenewswire.com
3 Reasons Growth Investors Will Love LeMaitre (LMAT)
May 07, 2026 09:45 AM · zacks.com
LeMaitre (LMAT) Upgraded to Buy: Here's Why
May 07, 2026 09:00 AM · zacks.com
LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript
May 05, 2026 08:51 PM · seekingalpha.com